Kelly Gao
About Kelly Gao
Kelly Gao is a Senior Specialist in Clinical Science at Boston Scientific, with a background in medical affairs and field medical roles across APAC, and extensive research experience from Carleton University.
Current Position at Boston Scientific
Kelly Gao has been serving as the Senior Specialist, Clinical Science for the APAC region at Boston Scientific since 2020. In this role, she focuses on clinical science operations and supports the development and implementation of clinical research programs. Her responsibilities include overseeing clinical trials, managing research data, and ensuring compliance with regulatory standards within the APAC market.
Previous Roles at Boston Scientific
Before her current role, Kelly Gao was a Medical Specialist in the Medical Affairs division at Boston Scientific from 2019 to 2020. In this capacity, she provided medical insights and supported clinical research initiatives. Her experience in this role further solidified her expertise in clinical science, particularly within the APAC region.
Experience at BTG plc
Kelly Gao worked at BTG plc as a Medical Specialist in the Field Medical team for the APAC region from 2015 to 2020, based in Hong Kong. Prior to that, she was a Medical Specialist in Ottawa, Canada, for 11 months in 2015. Her tenure at BTG plc involved extensive fieldwork and the development of medical strategies to support various interventional oncology projects.
Academic and Research Background
Kelly Gao has an extensive academic background from Carleton University, where she was a Research Associate from 2010 to 2014, a Research and Teaching Assistant from 2008 to 2010, and an Academic Program Coordinator from 2007 to 2013. She has contributed significantly to research projects and academic programs, demonstrating her strong skills in training and research.
Educational Qualifications
Kelly Gao holds a Doctor of Philosophy (PhD) in Biomedical Sciences from the University of Macau, earned from 2018 to 2022. She also has a Master's degree in Biochemistry and Molecular Biology, completed from 2008 to 2010, and a Bachelor's Degree in Biochemistry from 2004 to 2008, both from Carleton University. Her educational background underpins her expertise in interventional oncology and biomedical sciences.